SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
We determined the immunoreactive opsin content in the subretinal fluid from 16 patients with rhegmatogenous retinal detachment by enzyme-linked immunosorbent assay. The opsin content decreased, with the duration of the detachment, but there was no correlation between opsin content and the age of the patient or the extent of the retinal detachment.
Explore the source record for details and available documents.
Three cases of bullous superior rhegmatogenous retinal detachment were surgically repaired by circumferential scleral buckling and intravitreal air injection. Unusual retinal folds were found postoperatively. Unlike the well-recognized radial retinal folds classically associated with circumferential buckling of bullous retinal detachments, the folds reported herein originated from the "end" of a hard silicone exoplant and traversed an arcuate course corresponding to the lower meniscus of the intravitreal air bubble. Although the macula was involved in all three cases, the retinal break was unaffected.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Evidence is presented that idiopathic senile macular hole is caused by focal shrinkage of the vitreous cortex in the foveal area. The most reliable biomicroscopic signs of impending hole formation (stage 1) are the development of a yellow spot or ring in the center of the fovea, loss of the foveal depression, and no evidence of separation of the vitreous from the foveal retina. Although in a majority of eyes with stage 1 changes there is a progression to hole formation, spontaneous separation of the vitreous without hole formation may occur in some cases (44%) and cause characteristic biomicroscopic changes, including foveal reattachment, disappearance of the yellow spot or ring, and, in some cases, a pseudo-operculum, with one or more lamellar holes or facets. A prospective collaborative study is recommended to confirm these findings and to test the clinical value of surgical peeling of the vitreous cortex in eyes with stage 1 changes as a means of preventing hole formation.
Explore the source record for details and available documents.
We review our experience and present an analysis of 119 consecutive cases of macular pucker treated by vitrectomy and removal of the epiretinal tissue following treatment for acute retinal tears (16 eyes) or rhegmatogenous retinal detachment (103 eyes). Vision improved postoperatively in 104 (87%) of the 119 eyes. Final visual acuity of 20/60 or better was achieved in 38 (75%) of 51 cases in which the macula had not been detached previously and in 12 (24%) of 52 cases with prior macular detachment. Two preoperative factors were associated with a final visual acuity of 20/100 or better: (1) macula not involved by the original retinal detachment, and (2) thin epiretinal membrane.
In each of three phakic eyes, a full-thickness macular hole developed after scleral buckling surgery for repair of a rhegmatogenous retinal detachment. Presumed predisposing factors included retinal ischemia in the central fovea due to separation of the retina from the choroidal vascular supply and vitreomacular traction.
Explore the source record for details and available documents.
In a prospective study of macular hole formation, focal electroretinograms (ERGs) were obtained from both eyes of 35 patients with a unilateral, idiopathic, full-thickness macular hole. Foveal cone ERG amplitude was significantly correlated with hole diameter at the initial visit. Twenty-six patients had normal foveal cone ERGs in the fellow eye at the baseline visit and for the duration of the study (mean follow-up, 35 months; range, 24 to 56 months). None of these eyes developed a macular hole. Seven eyes had significantly reduced foveal cone ERGs in the fellow eye, despite good visual acuity and a normal-appearing macula on the initial visit. Four of these eyes subsequently developed a full-thickness macular hole during follow-up (mean follow-up, 35 months; range, 25 to 46 months). Foveal ERG amplitude was significantly related to subsequent macular hole formation, suggesting that this test can provide an objective measure of macular function to help identify eyes at risk for macular hole formation.
We reviewed 55 consecutive cases of rhegmatogenous retinal detachment treated with pneumatic retinopexy. Eyes with inferior retinal breaks from the 4- to 8-o'clock positions or macular holes with retinal detachment were excluded. Forty-five eyes (82%) were reattached with one operation. Although ten operations failed, nine retinas were subsequently reattached surgically, a 98% overall reattachment rate. Thirty-three (92%) of 36 phakic eyes, eight (66%) of 12 pseudophakic eyes, and four (57%) of seven aphakic retinas were reattached with one operation. In macula-off cases, phakic patients tended to have greater improvement in visual acuity. New breaks occurred in six eyes (11%), five (83%) of which were pseudophakic or aphakic. The safety, efficacy, and indications for pneumatic retinopexy remain to be established by a randomized, controlled, prospective study.
Transforming growth factor beta (TGF-beta) stimulates fibrosis. We studied its possible role as a bioactive substance for inducing localized chorioretinal wound healing along the edge of a retinal tear. The TGF-beta was applied to induced retinal tears that were examined histopathologically. One day after surgery, neither control nor TGF-beta-treated eyes developed chorioretinal wound healing. Four days, two weeks, and two months after surgery, the control eyes still had not developed chorioretinal wound healing. In contrast, the edges of the retinal tear treated with TGF-beta were adherent to the underlying Bruch's membrane via localized fibrous tissue without apparent effects elsewhere. These results demonstrate intraocular in vivo bioactivity of TGF-beta and suggest that TGF-beta may have a potential role as an alternative means for inducing a chorioretinal adhesion in the treatment of retinal tears.
Three low-viscosity perfluorocarbon liquids provided an intraoperative tool during vitrectomy to manage giant retinal tears. These clear fluids have a high specific gravity (1.8 to 1.9) and are immiscible with water. In six eyes, the giant tear was less than 180 degrees; in 11 eyes, it was 180 degrees or greater. In all eyes, the tear was unfolded and the retina was flattened while the patient was supine. The perfluorocarbon liquid was aspirated and replaced by air-perfluorocarbon gas mixtures (16 eyes) or silicone oil (one eye) at the end of the operation. The retina was reattached in 16 eyes (94%), with a minimum follow-up period of 6 months. In five eyes (29%), the retina was reattached without scleral buckling. Residual droplets of perfluorocarbon liquid were observed in four patients. These new materials complement present surgical techniques for managing giant retinal tears.
Three patients who had been treated with transscleral cryotherapy to the avascular retina for stage 3+ retinopathy of prematurity with threshold disease had total rhegmatogenous retinal detachments develop. In each case, the retinal detachment developed more than 1 year after treatment and resulted from a tear at the junction of the treated and untreated retina. Rhegmatogenous retinal detachment is a late complication of transscleral cryotherapy that to our knowledge has not previously been documented.
The location of retinal breaks found on preoperative examination was studied in 68 eyes of 68 patients with recurrent retinal detachment and proliferative vitreoretinopathy. Twelve eyes had 23 open breaks that were known to exist previously, no open break was detected in 18 eyes, and 72 new or previously unidentified breaks were found in 41 eyes. Forty-seven (65.3%) of the 72 breaks were located on previous buckles, and 31 of these were on the posterior slope of the buckle. Twenty-nine (40.2%) of all new or previously unidentified breaks were on the border of a cryopexy-induced chorioretinal scar, and of these, 25 breaks (86%) were on the posterior slope of the buckle. Our results indicate that the retina that borders chorioretinal scars is vulnerable and prone to develop retinal tears secondary to traction from preretinal membranes. The vicinity of cryopexy-induced scars should be closely observed for retinal breaks in cases of recurrent retinal detachment with proliferative vitreoretinopathy.
Intraocular gas bubbles can occlude retinal breaks and lead to retinal reattachment, but inferior breaks can be difficult to occlude. We hypothesized that an automated air injector connected to the eye would progressively fill the vitreous cavity with a bubble and occlude all, even inferior, breaks. This technique, termed continuous vitreous insufflation, was applied in 30 eyes of 15 rabbits using an air pressure of 50 mm Hg. Thirteen study eyes underwent lensectomy, vitrectomy, and rhegmatogenous retinal detachment; 17 eyes did not. In each eye with a patent cannula, a bubble virtually filled the vitreous cavity within about 24 hours, and all detached retinas became reattached except those with large breaks. Because large bubbles should be effective in closing most breaks, continuous vitreous insufflation may enable high reattachment rates. Accordingly, this procedure may prove valuable in treating certain retinal detachments in humans, although there are obstacles to clinical application.
Sodium hyaluronate (Healon) was used in conjunction with pars plana vitrectomy and scleral buckling to manage unilateral giant retinal tears of 180 degrees or more with severe folding in six consecutive cases. In each instance the retina was successfully flattened, and five of the six have remained so for at least one year. The technique enables the surgeon to unroll a retinal flap that is markedly inverted on itself and oppose it to the underlying retinal pigment epithelium.